🇺🇸 FDA
Patent

US 8951793

Method of making an isolated population of FOXP3+ regulatory T cells

granted A61KA61K2035/122A61K40/11

Quick answer

US patent 8951793 (Method of making an isolated population of FOXP3+ regulatory T cells) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Feb 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Feb 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K2035/122, A61K40/11, A61K40/22, A61K40/416